-
摘要: 目的:研究Ku蛋白表达与膀胱癌发生、进展的关系。方法:应用SP法对98例行经尿道膀胱肿瘤电切术(TURBT)、根治性膀胱切除术的膀胱组织标本进行免疫组织化学染色;应用形态计量学分析方法结合临床相关病理资料分析Ku蛋白表达与膀胱癌肿瘤相关指标的关系。结果:98例膀胱癌组织中Ku蛋白总阳性表达数为79例(80.61%)。67例非肌层浸润性膀胱癌组织中Ku蛋白阳性表达数为60例(89.55%),31例肌层浸润性膀胱癌中Ku蛋白阳性表达数为19例(61.29%),两者差异有显著统计学意义(P<0.01)。图像分析结果:肌层浸润性膀胱癌组(2 453.05±221.24)和非肌层浸润性膀胱癌组(4 349.41±307.20)之间积分光密度的差异有显著统计学意义(P<0.01)。肿瘤组织(3 605.67±1 024.80)与癌旁组织(396.84±60.24)之间积分光密度的差异度亦有显著统计学意义(P<0.01)。结论:Ku蛋白可能在膀胱癌进展的过程中发挥着重要作用。早期Ku蛋白表达增加是膀胱癌发生的一个重要因素。晚期Ku蛋白表达下调与膀胱癌的侵袭性密切相关。Abstract: Objective: To study the correlation between the expression of Ku proteins and the development and progression of carcinoma of bladder.Method: Ku proteins expression levels of 98 cases of samples which were obtained surgically by transurethral resection of bladder (TURBT) or radical cystectomy were examined by immunohistochemistry. The results were analyzed by morphometric analysis combined with the clinicopathologic data.Result: Of the 98 cases, 79 cases were positive for the expression of Ku proteins (80.61%). The percentage of positive expression of Ku proteins in the non muscle-invasive bladder cancer group (89.55%, 60/67) was significantly higher (P<0.01) than that of the muscle-invasive bladder cancer group (61.29%, 19/31). Morphometry demonstrated that mean optical density levels of Ku proteins of the non muscle-invasive bladder cancer group (4 349.41±307.20) was significantly higher (P<0.01) than that of the muscle-invasive bladder cancer group (2 453.05±221.24). There was a significant difference (P<0.01) between the carcinoma (3 605.67± 1 024.80) and the bladder tissues adjacent to the carcinoma (396.84±60.24).Conclusion: Ku proteins may play an important role in the progressive processes. The increasing expression of Ku proteins may be one important mechanism of earlier phases of bladder cancer genesis. The down-regulating expression of Ku proteins is closely related with the invasion of carcinoma of bladder.
-
Key words:
- Ku proteins /
- carcinoma of bladder /
- muscle-invasive /
- immunohistochemistry /
- image analysis
-
-
[1] Mimori T, Akizuki M, Yamagata H, et al. Characterization of a high molecular weight acidic nuclear protein recognized by autoantibodies in sera from patients with polymyositis-scleroderma overlap[J]. J Clin Invest, 1981, 68(3):611-620.
[2] Lieber M R. The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway[J]. Annu Rev Biochem, 2010, 79:181-211.
[3] Grob P, Zhang T T, Hannah R, et al. Electron microscopy visualization of DNA-protein complexes formed by Ku and DNA ligase IV[J]. DNA Repair, 2012, 11 (1):74-81.
[4] Fleck O, Nielsen O. DNA repair[J].J Cell Sci, 2004, 117(Pt 4):515-517.
[5] Sibanda B L, Chirgadze D Y, Blundell T L. Crystal structure of DNA-PKcs reveals a large open-ring cradle comprised of HEAT repeats[J]. Nature, 2010, 463(7277):118-121.
[6] Douglas P, Cui X P, Block W D, et al. The DNA-dependent protein kinase catalytic subunit is phosphorylated in vivo on threonine 3950, a highly conserved amino acid in the protein kinase domain[J]. Mol Cell Biol, 2007, 27(5):1581-1591.
[7] Liu Q H, Li L M, Wang J F. Expression and significance of hTERT, P53 and Ki-67 in astrocytoma by tissue microarray[J]. Chin Remedies Clin, 2005, 5(5):354-356.
[8] Lu H, Shimazaki N, Raval P, et al. A biochemically defined system for coding joint formation in V(D)J recombination[J]. Mol Cell, 2008, 31(4):485-497.
[9] Mahaney B L, Meek K, Lees-Miller S P. Repair of ionizing radiation-induced DNA double-strand breaks by non-homologous end-joining[J]. Biochem, 2009, 417(3):639-650.
[10] Neal J A, Dang V, Douglas P, et al. Inhibition of homologous recombination by DNA-dependent protein kinase requires kinase activity, is titratable, and is modulated by autophosphorylation[J]. Mol Cell Biol, 2011, 31(8):1719-1733.
[11] Hammel M, Yu Y, Mahaney B L, et al. Ku and DNA-dependent protein kinase dynamic conformations and assembly regulate DNA binding and the initial non-homologous end joining complex[J].J Biol Chem, 2010, 285(2):1414-1423.
[12] Yu Y, Mahaney B L, Yano K, et al. DNA-PK and ATM phosphorylation sites in XLF/Cernunnos are not required for repair of DNA double strand breaks[J]. DNA Repair, 2008, 7(10):1680-1692.
[13] Lim D S, Vogel H, Willerford D M, et al. Analysis of Ku80-mutant mice and cells with deficient levels of p53[J]. Mol Cell Biol, 2000, 20(11):3772-3780.
[14] Gaymes T J, Mufti G J, Rassool F V. Myeloid leukemias have increased activity of the non-homologous end-joining pathway and concomitant DNA misrepair that is dependent on the Ku70/86 heterodimer[J]. Cancer Res, 2002, 62(10):2791-2797.
[15] Korabiowska M, Tscherny M, Grohmann U, et al. Decreased expression of Ku70/Ku80 proteins in malignant melanomas of the oral cavity[J]. Anticancer Res, 2002, 22(1A):193-196.
[16] Pucci S, Mazzarelli P, Rabitti C, et a1. Tumor specific modulation of KU70/80 DNA binding activity in breast and bladder human tumor biopsies[J]. Oncogene, 2001, 20(6):739-747.
[17] Komuro Y, Watanabe T, Hosoi Y, et al. The expression pattern of Ku correlates with tumor radiosensitivity and disease free survival in patients with rectal carcinoma[J]. Cancer, 2002, 95(6):1199-1205.
[18] Kinzler K W, Vogelstein B. Cancer-susceptibility genes. Gatekeepers and caretakers[J]. Nature, 1997, 386(6627):761, 763.
[19] Difilippantonio M J, Zhu J, Chen H T, et al. DNA repair protein Ku80 suppresses chromosomal aberrations and malignant transformation[J]. Nature, 2000, 404(6777):510-514.
[20] Holgersson A, Erdal H, Nilsson A, et al. Expression of DNA-PKcs and Ku86, but not Ku70, differs between lymphoid malignancies[J]. Exp Mol Pathol, 2004, 77(1):1-6.
[21] Rigas B, Borgo S, Elhosseiny A, et al. Decreased exp ression of DNA-dependent protein kinase, a DNA repair protein, during human colon carcinogenesis[J]. Cancer Res, 2001, 61(23):8381-8384.
[22] Stronati L, Gensabella G, Lamberti C, et al. Expression and DNA binding activity of the Ku heterodimer in bladder carcinoma[J]. Cancer, 2001, 92(9):2484-2492.
-
计量
- 文章访问数: 25
- PDF下载数: 72
- 施引文献: 0